342 related articles for article (PubMed ID: 31903124)
1. Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation.
Yun CY; Roh E; Kim SH; Han J; Lee J; Jung DE; Kim GH; Jung SH; Cho WJ; Han SB; Kim Y
Theranostics; 2020; 10(1):340-352. PubMed ID: 31903124
[No Abstract] [Full Text] [Related]
2. Interruption of p38
Kim SH; Lee J; Jung J; Kim GH; Yun CY; Jung SH; Hwang BY; Hong JT; Han SB; Jung JK; Kim Y
Int J Biol Sci; 2024; 20(5):1688-1704. PubMed ID: 38481807
[No Abstract] [Full Text] [Related]
3. Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation.
Kim SH; Na C; Yun CY; Kim JG; Baek ST; An HJ; Lee JD; Lee SW; Jung JK; Hwang BY; Han SB; Kim Y
Int J Biol Sci; 2024; 20(1):312-330. PubMed ID: 38164184
[No Abstract] [Full Text] [Related]
4. Nuclear Entry of CRTC1 as Druggable Target of Acquired Pigmentary Disorder.
Yun CY; Hong SD; Lee YH; Lee J; Jung DE; Kim GH; Kim SH; Jung JK; Kim KH; Lee H; Hong JT; Han SB; Kim Y
Theranostics; 2019; 9(3):646-660. PubMed ID: 30809299
[No Abstract] [Full Text] [Related]
5. Abrogating effect of a xanthophyll carotenoid astaxanthin on the stem cell factor-induced stimulation of human epidermal pigmentation.
Nakajima H; Fukazawa K; Wakabayashi Y; Wakamatsu K; Senda K; Imokawa G
Arch Dermatol Res; 2012 Dec; 304(10):803-16. PubMed ID: 22639095
[TBL] [Abstract][Full Text] [Related]
6. The stem cell factor-stimulated melanogenesis in human melanocytes can be abrogated by interrupting the phosphorylation of MSK1: evidence for involvement of the p38/MSK1/CREB/MITF axis.
Niwano T; Terazawa S; Nakajima H; Imokawa G
Arch Dermatol Res; 2018 Apr; 310(3):187-196. PubMed ID: 29362867
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cells inhibit melanin production by activation of Wnt inhibitors.
Hwang I; Park JH; Park HS; Choi KA; Seol KC; Oh SI; Kang S; Hong S
J Dermatol Sci; 2013 Dec; 72(3):274-83. PubMed ID: 24016750
[TBL] [Abstract][Full Text] [Related]
8. Withaferin A abolishes the stem cell factor-stimulated pigmentation of human epidermal equivalents by interrupting the auto-phosphorylation of c-KIT in human melanocytes.
Terazawa S; Nakajima H; Fukasawa K; Imokawa G
Arch Dermatol Res; 2015 Jan; 307(1):73-88. PubMed ID: 25376854
[TBL] [Abstract][Full Text] [Related]
9. Nobiletin, a polymethoxy flavonoid, reduced endothelin-1 plus SCF-induced pigmentation in human melanocytes.
Kim HJ; Yonezawa T; Teruya T; Woo JT; Cha BY
Photochem Photobiol; 2015; 91(2):379-86. PubMed ID: 25488359
[TBL] [Abstract][Full Text] [Related]
10. CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders.
Yoo H; Lee HR; Kim KH; Kim MA; Bang S; Kang YH; Kim WH; Song Y; Chang SE
Theranostics; 2021; 11(20):9918-9936. PubMed ID: 34815795
[No Abstract] [Full Text] [Related]
11. [4-t-butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs.
Na YJ; Baek HS; Ahn SM; Shin HJ; Chang IS; Hwang JS
Biochem Pharmacol; 2007 Sep; 74(5):780-6. PubMed ID: 17658483
[TBL] [Abstract][Full Text] [Related]
12. Glucosamine abrogates the stem cell factor + endothelin-1-induced stimulation of melanogenesis via a deficiency in MITF expression due to the proteolytic degradation of CREB in human melanocytes.
Niwano T; Terazawa S; Sato Y; Kato T; Nakajima H; Imokawa G
Arch Dermatol Res; 2018 Oct; 310(8):625-637. PubMed ID: 30046896
[TBL] [Abstract][Full Text] [Related]
13. Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin.
Hasegawa J; Goto Y; Murata H; Takata M; Saida T; Imokawa G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):687-99. PubMed ID: 19086131
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MITF degradation.
Lee CS; Park M; Han J; Lee JH; Bae IH; Choi H; Son ED; Park YH; Lim KM
J Invest Dermatol; 2013 Apr; 133(4):1063-71. PubMed ID: 23223141
[TBL] [Abstract][Full Text] [Related]
16. Manassantin A inhibits cAMP-induced melanin production by down-regulating the gene expressions of MITF and tyrosinase in melanocytes.
Lee HD; Lee WH; Roh E; Seo CS; Son JK; Lee SH; Hwang BY; Jung SH; Han SB; Kim Y
Exp Dermatol; 2011 Sep; 20(9):761-3. PubMed ID: 21569106
[TBL] [Abstract][Full Text] [Related]
17. Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation.
Trivedi A; Mehrotra A; Baum CE; Lewis B; Basuroy T; Blomquist T; Trumbly R; Filipp FV; Setaluri V; de la Serna IL
Epigenetics Chromatin; 2020 Mar; 13(1):14. PubMed ID: 32151278
[TBL] [Abstract][Full Text] [Related]
18. JNK suppresses melanogenesis by interfering with CREB-regulated transcription coactivator 3-dependent MITF expression.
Kim JH; Hong AR; Kim YH; Yoo H; Kang SW; Chang SE; Song Y
Theranostics; 2020; 10(9):4017-4029. PubMed ID: 32226536
[TBL] [Abstract][Full Text] [Related]
19. cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.
Shin H; Hong SD; Roh E; Jung SH; Cho WJ; Park SH; Yoon DY; Ko SM; Hwang BY; Hong JT; Heo TY; Han SB; Kim Y
Br J Pharmacol; 2015 Jul; 172(13):3434-45. PubMed ID: 25766244
[TBL] [Abstract][Full Text] [Related]
20. A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes.
Huber WE; Price ER; Widlund HR; Du J; Davis IJ; Wegner M; Fisher DE
J Biol Chem; 2003 Nov; 278(46):45224-30. PubMed ID: 12944398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
